Cilfa Opposition, Glicopyrronium Formoterol, (Ar098982 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)
Countries: Argentina Date: 2016
-
CILFA opposition, Navafenterol sacchrinate in combination with corticosteroids, (AR094910A1)
Countries: Argentina Date: 2016
-
CILFA opposition, tobramycin, (AR092318A1)
Countries: Argentina Date: 2015
-
CILFA opposition, bromhexine, (AR082381A1)
Countries: Argentina Date: 2013
-
CILFA opposition, Ezetimibe and Rosuvastatin, (AR098996A1)
Countries: Argentina Date: 2016
-
CILFA opposition, brigatinib, (AR111169A1)
Countries: Argentina Date: 2019
-
CILFA opposition, mesalazine, (AR108231A1)
Countries: Argentina Date: 2018
-
CILFA opposition, estradiol, (AR107022A1)
Countries: Argentina Date: 2019
-
CILFA opposition, fenibrutinib, (AR107751A1)
Countries: Argentina Date: 2018
-
CILFA opposition, LAS191954, (AR100620A1)
Countries: Argentina Date: 2017